Traildog19 Posted - 3 hours ago

$ACHV Are those 13.9M shares on the 4/26 S-3 new created shares to be sold ATM or shares created by the last round of financing?

JPecton Posted - 7 hours ago

$ACHV Watching this one!

MrTicker Posted - 7 hours ago

$ACHV just hit the scanner for volume and share price increase

MrTicker Posted - 10 hours ago

$ACHV nice spread to the upside..

ENTSURGEON Posted - 04/27/24

$ACHV I know to take this with a grain of salt but it’s still nice to see!!

kpkelly777 Posted - 04/26/24

$ACHV here’s how many shares they have as of April 24’

DonCorleone77 Posted - 04/26/24

$ACHV Achieve Life Sciences files to sell 13.09M shares of common stock for holders

MrTicker Posted - 04/26/24

$ACHV Form S-3 ACHIEVE LIFE SCIENCES, 10K WIZARD 3:35 PM ET 4/26/2024 http://archive.fast-edgar.com/20240426/A3262222ZZ22C24Z2Z9A2M42GPCQZK22Z262 Filed on: April 26, 2024

MrTicker Posted - 04/26/24

$ACHV Form DEF 14A ACHIEVE LIFE SCIENCES, For: Jun 05 10K WIZARD 3:06 PM ET 4/26/2024 http://archive.fast-edgar.com/20240426/AV2ZJ222ZZ22O2AZ2Z9U2242QSBTZK22ZX62 Filed on: April 26, 2024

drdoctor7 Posted - 04/25/24

$ACHV Anyone expect any new exciting updates on May 9th. Or just plain ol' "We are committed to bringing our product to market with a major company with an established sales force" and "We are presenting at an investors conference at the Gold Nugget casino".

Stock_Titan Posted - 04/25/24

$ACHV Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 https://www.stocktitan.net/news/ACHV/achieve-life-sciences-to-announce-first-quarter-financial-results-mrfd584ndpbk.html

MrTicker Posted - 04/23/24

$ACHV Form 4 ACHIEVE LIFE SCIENCES, For: Apr 19 Filed by: Wan Jerry 10K WIZARD 3:39 PM ET 4/23/2024 http://archive.fast-edgar.com/20240423/AI2G3Q22ZZ229ZAZ25932Z42QFJ5ZK22Z262 Filed on: April 23, 2024

RallyRaider Posted - 04/22/24

$ACHV why does Hunt family invest here?

RallyRaider Posted - 04/22/24

$ACHV who owns this and why? Can take Chantix place, is probably even superior? Chantix saw peak global sales at 1.1bln

Stocksrunner Posted - 04/18/24

🔥 Analyst Upgrades 📈: $ACHV JonesTrading throws fuel on the fire, initiating coverage of Achieve Life Sciences with a spicy Buy recommendation, igniting excitement among investors. $OSK highlighting a tantalizing mix of low P/S ratios and strong cash flow. $STRA Truist Securities turns up the heat, upgrading Strategic Education from Hold to Buy, signaling a shift to full throttle confidence. Stay tuned for more sizzling analyst insights! https://stocksrunner.com/trending

Stocksrunner Posted - 04/18/24

📈 Today's Analyst Upgrades: $AMZN Maxim Group Initiates Coverage with Buy Recommendation. Analyst Price Forecast Suggests 18.22% Upside Potential. $ACHV JonesTrading Initiates Coverage of Achieve Life Sciences with Buy Recommendation $OSK Upgraded Based on Value Investing Metrics $STRA Truist Securities Upgrades Strategic Education to Buy https://stocksrunner.com/upgrades

MrTicker Posted - 04/17/24

$ACHV JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target MT NEWSWIRES 6:47 AM ET 4/17/2024 07:47 AM EDT, 04/17/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

Quantumup Posted - 04/16/24

JonesResearch🏁 $ACHV Buy/$20~believes now is the time2BUY as Co transition from a clinical2a comm Co; sees sig opp4cytisinicline2take mkt shr in the smoking cessation mkt. 📝Co seeking pot non-dilutive $ 4a pivotal trial in e-cigarette cessation, which could=label expansion 1H27: $pfe

DonCorleone77 Posted - 04/16/24

$ACHV Achieve Life Sciences initiated with a Buy at JonesResearch JonesResearch initiated coverage of Achieve Life Sciences with a Buy rating and $20 price target. Achieve is a clinical-stage biopharmaceutical company working to develop and commercialize cytisinicline for tobacco cessation, the analyst tells investors in a research note. The firm believes now is the right time for investors to but Achieve in its transition from a clinical to a commercial biopharmaceutical company. The company is seeking potential non-dilutive funding support for a pivotal trial in e-cigarette cessation, which could see a label expansion for cytisinicline in the first half of 2027, according to Jones.

bobtheknob Posted - 04/16/24

$ACHV Yeah just another boring Achieve presentation at a boring conference later this week with zero impact on the boring stock price.

Jokerjoker Posted - 04/15/24

$ACHV we call this the doldrums

Stock_Titan Posted - 04/11/24

$ACHV Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference https://www.stocktitan.net/news/ACHV/achieve-life-sciences-to-present-at-life-science-innovation-7i8lbv409ohk.html

AlertsAndNews Posted - 04/09/24

Good morning, gappers here this morning include $LASE $ACHV $BPTS $MYMD $SANG stay green!

bobtheknob Posted - 04/07/24

$ACHV Do you guys think a transaction(strategic partnership/buyout) would happen first half of this year? CEO said in December FDA speed bump will have no effect on preventing this transaction. Nobody asked about color on that statement from December interview in last CC.

Jokerjoker Posted - 04/04/24

@kpkelly777 Did you give up on $ACHV haven't seen you in awhile

Jokerjoker Posted - 04/04/24

$ACHV nice article on seeking alpha the link if it let's you look at it https://seekingalpha.com/article/4682106?gt=9355d704b3d43739

Greyhound14 Posted - 04/02/24

@mhbrown24 The numbers are actually relatively easy to model now for $ACHV. The CEO said in the US there were 8mm Rx’s written last year. He also said that he plans to charge around $1500/12 week treatment that insurance is required to cover, and that the US market should account for 75% of total revenue. What we don’t know is how much $ACHV owes Sopharma and/or other manufacturers. My guess is that we end up with around 15% net income margins. So if you think we might get 30% of all new Rx’s at $1500… [(8mm x .30) x $1500] x .15 = $540mm net income. With 55mm O/S, $540mm / 55 million = $9.81 EPS. Assign whatever P/E multiple you wish. I use 15x. $9.81 x 15 = $147. I’d expect a buyout to be at 30-50% of the intrinsic “go at it alone” value of domestic sales.

cgcapitalresearch Posted - 04/02/24

$ACHV: 4Q Review: NDA Train for Cytisinicline Firmly On Track; Reiterating $14 Price Target and OUTPERFORM Rating - Read More: https://hubs.ly/Q02rylkV0

Vesuvius Posted - 04/02/24

$ACHV Thought I'd post the SRNT abstract they discussed in the last PR. Will take several posts: PPS1-3 POST-TRIAL SURVEYS FROM TWO PHASE 3 (ORCA-2 AND ORCA-3) TRIALS OF CYTISINICLINE IN ADULT SMOKERS Significance: The Phase 3 ORCA-2 and ORCA-3 clinical trials evaluated efficacy and safety of 3 mg cytisinicline dosed 3x daily (TID) for 6 or 12 weeks compared to placebo in adult smokers. In total, 1066 and 535 subjects received cytisinicline and placebo respectively. A voluntary post-trial survey was offered to all participants to gain insight into their experience with cytisinicline. Methods: Following database lock and unblinding of each study, participants were provided their individual treatment assignment and were asked to complete a 15-minute online survey. Study Subject ID number was used to link the information provided by participants to their assigned study treatment and outcome for smoking cessation.

Supermoto87 Posted - 03/29/24

$ACHV Is this good?